AI Assistant
Blog
Pricing
Log In
Sign Up
Venetoclax in upfront induction therapy for primary plasma cell leukemia with t(11;14) or BCL2 expression
Details
Cite
Export
Add to List
This content is not available in your region!
Continue researching
here.